Novavax
NVAX
#5751
Rank
NZ$1.94 B
Marketcap
NZ$12.00
Share price
0.73%
Change (1 day)
-14.98%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$2.32 Billion

According to Novavax's latest financial reports the company's total liabilities are NZ$2.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$3.87 B-2.59%
2023-12-31NZ$3.97 B-12.74%
2022-12-31NZ$4.55 B6.27%
2021-12-31NZ$4.28 B223.83%
2020-12-31NZ$1.32 B148.39%
2019-12-31NZ$0.53 B-4.89%
2018-12-31NZ$0.56 B-1.54%
2017-12-31NZ$0.56 B-1.4%
2016-12-31NZ$0.57 B323.13%
2015-12-31NZ$0.13 B130.44%
2014-12-31NZ$59.19 M52.54%
2013-12-31NZ$38.8 M44.42%
2012-12-31NZ$26.87 M64.78%
2011-12-31NZ$16.3 M-20.35%
2010-12-31NZ$20.47 M-5.01%
2009-12-31NZ$21.55 M-59.83%
2008-12-31NZ$53.65 M45.6%
2007-12-31NZ$36.84 M-6.87%
2006-12-31NZ$39.56 M-22.13%
2005-12-31NZ$50.81 M-18.91%
2004-12-31NZ$62.66 M-15.52%
2003-12-31NZ$74.17 M-21.47%
2002-12-31NZ$94.45 M-1.01%
2001-12-31NZ$95.41 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
NZ$0.89 B-61.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.77 B 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.52 B-34.27%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.44 B-37.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.90 B 5,023.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$200.76 B 8,551.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.57 B 4,578.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
NZ$2.26 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.40 B 4,485.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$86.94 M-96.25%๐Ÿ‡บ๐Ÿ‡ธ USA